Oppenheimer sees the S&P 500 rallying nearly 12% in 2023 as corporate earnings hold up
The Wall Street shop is more bullish than many of its peers about the outlook for the next year.
Goldman says it’s ‘difficult’ to envision a scenario where market goes substantially higher in 2023
“It is difficult to outline a realistic scenario that drives the S&P 500 substantially higher next year,” said Goldman’s David Kostin.
Police in China arrest gang who laundered $1.7 billion via crypto even after Beijing’s crackdown
Police in China arrested 63 people accused of laundering as much as 12 billion Chinese yuan ($1.7 billion) via cryptocurrency Tether.
Iran executes second protester after rapid trial as EU plans more sanctions
Iran has long held what activists and other governments say are sham trials in order to imprison or execute critics of the state.
U.S. Justice Department reportedly split over charging Binance as crypto world falters
Splits between U.S. Department of Justice prosecutors are delaying a long-running criminal investigation into the cryptocurrency exchange Binance.
Trust between the West and Russia has been destroyed, NATO chief says
Russia continues to pound Ukraine’s energy infrastructure too with devastating consequences for civilians.
Elon Musk booed by crowd after Dave Chappelle brings him on stage at comedy gig
Tesla boss Elon Musk is facing criticism over his handling of Twitter since buying that social media platform. His tweets have angered Democrats, LGBTQ activists and others.
Rivian pauses plans to make electric vans in Europe with Mercedes-Benz
Rivian said it remains open to exploring future work with Mercedes-Benz “at a more appropriate time.”
Microsoft buys near 4% stake in London Stock Exchange Group as part of 10-year cloud deal
U.S. tech giant Microsoft on Monday announced a 10-year partnership with the London Stock Exchange and took a near 4% stake in the U.K. bourse operator.
Bioscience firms Novozymes and Chr. Hansen to merge in biggest-ever Danish deal
Novozymes and Chr. Hansen have agreed to merge in a massive deal for Europe’s biotech sector.
